Socialiya - Entertainment. Knowledge. Community.
AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion

Deal adds an experimental drug for moderate to severe atopic dermatitis, building up AbbVie's core b...

BUSINESS NEWS June 22, 2026

AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion

Deal adds an experimental drug for moderate to severe atopic dermatitis, building up AbbVie's core business.

2 views 0 likes 0 comments
Share:
Deal adds an experimental drug for moderate to severe atopic dermatitis, building up AbbVie's core business.

Related News

Advertisement
socialiya
Advertisement
APNA POS
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
APNA POS
Advertisement
APNA POS